The involvement of platelet-activating factor in hyperacute xenogeneic rejection and its modulation by the PAF-antagonist WEB 2086BS.
Saumweber
D M
DM
Institute for Surgical Research, University of Munich, FRG.
Bergmann
R
R
Gokel
M
M
Brecht
H M
HM
Hammer
C
C
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000208:Acute Disease; D000818:Animals; D001381:Azepines / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection; D006464:Hemoperfusion; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors / Q000502:physiology*; D013552:Swine; D013929:Thromboxane B2 / Q000097:blood; D014183:Transplantation, Heterologous / Q000276:immunology*; D014230:Triazoles / Q000627:therapeutic use*
D001381:Azepines; D010972:Platelet Activating Factor; D014230:Triazoles; C052518:WEB 2086; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha